Influenza pandemic could cost Canadian economy $9 billion

    Over half of Canadian critical industry workers may not show up to work
    during a flu pandemic

    TORONTO, Dec. 12 /CNW/ - Immediate action to ensure employee health and
safety during an influenza pandemic is critical, according to a national
survey. Results show that 54 per cent of critical industry workers would be
uncomfortable going to work if several people in their city or town were
diagnosed with pandemic influenza. However, over 90 per cent of respondents
said that they would be more likely to report to work if they knew their
employer had plans to provide them with preventative flu medicines.
    Guy Holburn, Associate Professor at the University of Western Ontario's
Richard Ivey School of Business, estimates that this level of absenteeism
amongst critical industry workers, and the domino effect on other businesses,
could cost the Canadian economy $9 billion.
    "This survey indicates that a pandemic flu outbreak would create an
immediate and substantial negative impact on the economy, caused by high
levels of absenteeism amongst critical infrastructure workers," said Professor
Holburn. While only a minority of the labour force would miss work due to
illness, a substantial proportion would not report to work due to concerns
about exposure and possible infection.
    "The impact of this level of absenteeism in these critical industries
would have a significant negative multiplier effect on the short-term
performance of most other businesses, and $9 billion is likely a conservative
estimate," said Professor Holburn. "Economic activity in all industries
depends on the reliable functioning of critical infrastructure sectors such as
electricity, telecommunications and transportation. We tend to take these for
granted, but without them the whole economy could grind to a stand-still."
    The survey also finds that workers who are aware of a pandemic plan at
their workplace are more likely to report for duty than workers with no
knowledge of a pandemic plan. However, only a quarter of respondents (24 per
cent) indicated that their employer had a pandemic plan in place. "The
creation and communication of pandemic plans, as well as the provision of
preventative flu medicines, would encourage workers to report for work,
enabling businesses and the broader economy to function more effectively,"
said Professor Holburn.
    The survey included utility and regional/city workers, transportation
workers (including public transit, trucking, shipping and courier), banking,
communication providers (telephone, mobile, cable and IT), grocery/food
warehousing and medical product manufacturers (including pharmaceuticals,
diagnostics, warehousing and distribution). Together, these sectors account
for approximately 20 per cent of the economy - valued at more than
$220 billion in 2006 and employing more than 3 million workers.
    The national survey, conducted by Leger Marketing and sponsored by
GlaxoSmithKline, used a combination of telephone and online interviews with
1,300 workers in fields which are considered critical services sectors, and
with 700 workers in healthcare fields. More key findings are included at the
end of the release under "Note to the Editor".


    Antiviral resistance is an important factor in planning for a pandemic.
In response to recent reports that some strains of the H5N1 virus are
resistant to oseltamivir (marketed under the trade name Tamiflu), the U.S.
Department of Health and Human Services has changed its stockpiling strategy
to decrease the share of oseltamivir from 90 to 80 per cent and increase the
share of zanamivir (marketed under trade name Relenza(R)) from 10 to 20 per
cent.(1) In the U.K., an influential group of scientists has recommended the
government modify the national stockpile to 50 per cent zanamivir and 50 per
cent oseltamivir.(2)


    History shows that influenza pandemics have occurred three to four times
per century.(3) Scientists believe pandemic flu viruses develop in two key
ways. First, a new subtype can result from the mixing (or "re-assortment") of
human and avian viruses, which is what scientists believe started the last two
influenza pandemics in 1957 and 1968. Because humans had no defense against
the new strain, it spread rapidly around the globe, causing widespread illness
and higher rates of death compared to seasonal influenza. These pandemics each
resulted in more than one million deaths globally.
    Second, a new pandemic strain can develop if an avian influenza virus
changes (or mutates) into a virus that can cause human illness and spread
easily from person to person. This is likely how the "Spanish flu" killed
between 40 and 50 million people worldwide in 1918 and 1919, including about
50,000 in Canada.


    GlaxoSmithKline - one of the world's leading research-based
pharmaceutical and health-care companies - is committed to improving the
quality of human life by enabling people to do more, feel better and live
longer. In Canada, GlaxoSmithKline is among the top 15 investors in research
and development, contributing more than $176 million in 2006 alone. GSK is an
Imagine Caring Company, and is consistently recognized as one of the 50 Best
Employers in Canada. For company information, please visit

    NOTES TO EDITOR - Flu Pandemic Survey, conducted by Leger Marketing

    About the Survey

    -   A 13-minute survey was conducted between August 7th and August 23rd,
    -   With a national sample of 2,000 respondents, results can be
        considered accurate to within +/-2.2 per cent, 19 times out of 20.
        When looking at either critical industry or healthcare workers
        separately (1,300 and 700, respectively), results can be considered
        accurate to within +/-2.7 and +/-3.7 per cent respectively.
    -   Critical industry workers comprised of: utilities or city regional
        workers such as water, electricity, gas, garbage collection, parks
        and recreation, city hall and mail delivery; transportation such as
        trucking, shipping, courier and public transit; banking;
        communication providers such as telephone, mobile, cable and IT;
        grocery and food warehousing; and medical product manufacturers
        involved with pharmaceuticals, diagnostics, warehousing and

    Key Findings on Infrastructure/Critical Industry Workers

    -   Over half of critical industry workers are concerned about the
        possibility of a pandemic flu outbreak in Canada, and two-thirds
        think an outbreak is likely.
        -  Quebecers are the least concerned about an outbreak, while older
           Canadians and those who believe they have an important role to
           play during a pandemic situation are more concerned.

    -   Those who work for an employer with a pandemic plan in place are more
        likely to report to work during a pandemic flu outbreak.
        -  90 per cent of workers are likely to report to work if their
           employer provided them with preventative flu medicines in the
           event of a pandemic flu outbreak.

    -   55 per cent of workers are aware that there are medicines which can
        reduce or prevent the impact of pandemic flu.
        -  Only 35 per cent of critical industry workers get an annual flu

    -   If a flu pandemic was affecting people in their city or town, workers
        in Ontario are most likely to consider going to work, as are workers
        who are familiar with their role during a pandemic. Quebecers are
        least likely to report to work during an outbreak in their city, as
        are those with children at home.

    (1) The Congress of the United States, Congressional Budget Office. A
        Potential Influenza Pandemic: An Update on Possible Macroeconomic
        Effects and Policy Issues. May 22, 2006; revised July 27, 2006: 13-14
    (2) The Royal Society & the Academy of Medical Sciences, Pandemic
        influenza: science to policy, November 2006

For further information:

For further information: or an interview in Toronto, Montreal, Calgary
or Vancouver, please contact: Peter Schram, GlaxoSmithKline, (905) 819-3363;
NATIONAL Public Relations, TORONTO, Megan Spoore, (416) 848-1383,; MONTREAL, Dan Brennan, (514) 843-2325 ext. 3332,; CALGARY, Karissa Boley, (403) 444-1486,; VANCOUVER, Claire Munroe, (604) 691-7393,

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890